FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001138013> ?p ?o ?g. }

• W2001138013 abstract "CTRC-AACR San Antonio Breast Cancer Symposium: 2008 AbstractsAbstract #4062 Background: The 40S ribosomal S6 kinase 1 (S6K1) acts downstream of the mammalian Target of Rapamycin (mTOR), and is sensitive to inhibition by rapamycin. Chromosomal region 17q23 containing the RPS6KB1 gene is frequently amplified in breast cancer cells, and S6K1 is overexpressed in about 30% of cases. Overexpression of S6K1 correlates with increased rapamycin sensitivity. The role of S6K1 in disease development and progression is supported by the observation that S6K1 overexpression is associated with poor prognosis in breast cancer patients. However, the reason for high-level amplification of the RPS6KB1 gene specifically in breast cancer, and not other cancer types, and the identity of breast cell-specific S6K1 targets is not well understood. In this study, we report that S6K1 regulates growth of breast cancer cells by phosphorylating Estrogen Receptor α (ERα), and co-expression of S6K1 and ERα in breast cancer cells renders them sensitive to combination therapy with rapamycin and tamoxifen. Materials and Methods: Using immunoblot analysis we determined expression levels of S6K1 in breast cancer cell lines, and the phosphorylation status of ERα on Ser167 after serum or mitogen stimulation. We compared the effect of low-serum media, and rapamycin and/or 4-hydroxytamoxifen (4-HT) addition on breast cancer cell proliferation using neutral red uptake assay. Results: We determined that overexpression of S6K1 in breast cancer cells confers proliferative advantage in low serum, contributing to neoplastic transformation. Next, we wished to identify targets of S6K1 in control of proliferation of breast cancer cells. One of the proteins we identified as a target of S6K1 is ERα. ERα is frequently co-overexpressed with S6K1 in breast cancer cells, which could be an indication of co-selection, and ERα contains a putative S6K1 phosphorylation motif RERLAS167. We confirmed that ERα phosphorylation may be mediated by S6K1. We shown that in S6K1-overexpressing MCF7 cells, serum-stimulated ERα phosphorylation is rapamycin-sensitive. Moreover, ERα phosphorylation stimulated by insulin and tumor-promoting phorbol esters is also rapamycin-sensitive. S6K1 can phosphorylate ERα in an in vitro kinase assay. Lastly, shRNA-mediated suppression of S6K1 expression in MCF7 cells reduces ERα phosphorylation. Subsequently, we examined whether co-overexpression of S6K1 and ERα in breast cancer cells sensitizes them to combination therapy with rapamycin and tamoxifen. We analyzed proliferation of cells treated with rapamycin and/or 4-HT. We observed that in S6K1- and ERα-overexpressing cells, treatment with rapamycin and 4-HT resulted in greater inhibition of cell growth. Discussion: Our data suggest that one of the targets of S6K1 signaling in breast cancer cells is ERα, and together, these proteins promote breast cancer cell proliferation. The ultimate objective would be to determine whether combined inhibition of S6K1 and the estrogen receptor could be used as targeted therapy for patients with double positive expression of S6K1 and ER.Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 4062." @default.
• W2001138013 created "2016-06-24" @default.
• W2001138013 creator A5013556380 @default.
• W2001138013 creator A5014754785 @default.
• W2001138013 creator A5020165036 @default.
• W2001138013 creator A5023751275 @default.
• W2001138013 creator A5033797242 @default.
• W2001138013 creator A5045588142 @default.
• W2001138013 date "2009-01-15" @default.
• W2001138013 modified "2023-09-26" @default.
• W2001138013 title "Estrogen receptor α is a target of mTOR/S6K1 signaling in control of breast cancer cell proliferation." @default.
• W2001138013 doi "https://doi.org/10.1158/0008-5472.sabcs-4062" @default.
• W2001138013 hasPublicationYear "2009" @default.
• W2001138013 type Work @default.
• W2001138013 sameAs 2001138013 @default.
• W2001138013 citedByCount "1" @default.
• W2001138013 crossrefType "proceedings-article" @default.
• W2001138013 hasAuthorship W2001138013A5013556380 @default.
• W2001138013 hasAuthorship W2001138013A5014754785 @default.
• W2001138013 hasAuthorship W2001138013A5020165036 @default.
• W2001138013 hasAuthorship W2001138013A5023751275 @default.
• W2001138013 hasAuthorship W2001138013A5033797242 @default.
• W2001138013 hasAuthorship W2001138013A5045588142 @default.
• W2001138013 hasConcept C104202773 @default.
• W2001138013 hasConcept C121608353 @default.
• W2001138013 hasConcept C126322002 @default.
• W2001138013 hasConcept C134018914 @default.
• W2001138013 hasConcept C143998085 @default.
• W2001138013 hasConcept C2777176818 @default.
• W2001138013 hasConcept C2777949483 @default.
• W2001138013 hasConcept C2780482068 @default.
• W2001138013 hasConcept C502942594 @default.
• W2001138013 hasConcept C530470458 @default.
• W2001138013 hasConcept C62478195 @default.
• W2001138013 hasConcept C71924100 @default.
• W2001138013 hasConcept C84606932 @default.
• W2001138013 hasConcept C86554907 @default.
• W2001138013 hasConcept C86803240 @default.
• W2001138013 hasConcept C95444343 @default.
• W2001138013 hasConceptScore W2001138013C104202773 @default.
• W2001138013 hasConceptScore W2001138013C121608353 @default.
• W2001138013 hasConceptScore W2001138013C126322002 @default.
• W2001138013 hasConceptScore W2001138013C134018914 @default.
• W2001138013 hasConceptScore W2001138013C143998085 @default.
• W2001138013 hasConceptScore W2001138013C2777176818 @default.
• W2001138013 hasConceptScore W2001138013C2777949483 @default.
• W2001138013 hasConceptScore W2001138013C2780482068 @default.
• W2001138013 hasConceptScore W2001138013C502942594 @default.
• W2001138013 hasConceptScore W2001138013C530470458 @default.
• W2001138013 hasConceptScore W2001138013C62478195 @default.
• W2001138013 hasConceptScore W2001138013C71924100 @default.
• W2001138013 hasConceptScore W2001138013C84606932 @default.
• W2001138013 hasConceptScore W2001138013C86554907 @default.
• W2001138013 hasConceptScore W2001138013C86803240 @default.
• W2001138013 hasConceptScore W2001138013C95444343 @default.
• W2001138013 hasLocation W20011380131 @default.
• W2001138013 hasOpenAccess W2001138013 @default.
• W2001138013 hasPrimaryLocation W20011380131 @default.
• W2001138013 hasRelatedWork W1983733795 @default.
• W2001138013 hasRelatedWork W2058635899 @default.
• W2001138013 hasRelatedWork W2068022222 @default.
• W2001138013 hasRelatedWork W2094850099 @default.
• W2001138013 hasRelatedWork W2129507086 @default.
• W2001138013 hasRelatedWork W2160043536 @default.
• W2001138013 hasRelatedWork W2324954137 @default.
• W2001138013 hasRelatedWork W2586688899 @default.
• W2001138013 hasRelatedWork W2592213010 @default.
• W2001138013 hasRelatedWork W2593247253 @default.
• W2001138013 hasRelatedWork W2756305797 @default.
• W2001138013 hasRelatedWork W2756765053 @default.
• W2001138013 hasRelatedWork W2791781412 @default.
• W2001138013 hasRelatedWork W2791903469 @default.
• W2001138013 hasRelatedWork W2792509718 @default.
• W2001138013 hasRelatedWork W2887096145 @default.
• W2001138013 hasRelatedWork W2896886594 @default.
• W2001138013 hasRelatedWork W2900043421 @default.
• W2001138013 hasRelatedWork W2938766833 @default.
• W2001138013 hasRelatedWork W3013998940 @default.
• W2001138013 isParatext "false" @default.
• W2001138013 isRetracted "false" @default.
• W2001138013 magId "2001138013" @default.
• W2001138013 workType "article" @default.